英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

diverted    音标拼音: [dɑɪv'ɚtɪd] [dɪv'ɚtɪd]
adj. 分神

分神

diverted
adj 1: pleasantly occupied; "We are not amused" -Queen Victoria
[synonym: {amused}, {diverted}, {entertained}]

Divert \Di*vert"\, v. t. [imp. & p. p. {Diverted}; p. pr. & vb.
n. {Diverting}.] [F. divertir, fr. L. divertere, diversum, to
go different ways, turn aside; di- = dis- vertere to turn.
See {Verse}, and cf. {Divorce}.]
1. To turn aside; to turn off from any course or intended
application; to deflect; as, to divert a river from its
channel; to divert commerce from its usual course.
[1913 Webster]

That crude apple that diverted Eve. --Milton.
[1913 Webster]

2. To turn away from any occupation, business, or study; to
cause to have lively and agreeable sensations; to amuse;
to entertain; as, children are diverted with sports; men
are diverted with works of wit and humor.
[1913 Webster]

We are amused by a tale, diverted by a comedy. --C.
J. Smith.

Syn: To please; gratify; amuse; entertain; exhilarate;
delight; recreate. See {Amuse}.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
diverted查看　diverted　在百度字典中的解释百度英翻中〔查看〕
diverted查看　diverted　在Google字典中的解释Google英翻中〔查看〕
diverted查看　diverted　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • What treatment options are available for a patient with . . .
    Treatment Algorithm for Recurrent Metastatic Cervical Cancer After Platinum Failure Second-Line Treatment Selection Cemiplimab 350 mg IV every 3 weeks is an appropriate option regardless of PD-L1 status, based on NCCN recommendations and phase III evidence 1, 4 Alternative second-line options per NCCN include:
  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • Libtayo more favorable than Keytruda for first-line . . .
    The FDA approved Libtayo in 2022 as a first-line treatment for advanced NSCLC, in combination with chemotherapy However, it has been unclear whether this new combination treatment could outperform Keytruda plus chemotherapy from a cost-effectiveness standpoint
  • Treatment in Advanced NSCLC | LIBTAYO® (cemiplimab-rwlc)
    Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced non-small cell lung cancer (NSCLC) Review Important Safety Info Full Prescribing Information including Med Guide
  • New Treatment, New Hope for Those with Advanced Cutaneous . . .
    You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC) Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC This is exciting news, so let’s break down how this new drug works and whom it might help
  • Libtayo (cemiplimab) vs Krazati (adagrasib) - Everyone. org
    Libtayo (cemiplimab) vs Krazati (adagrasib) - Everyone org Everyone org
  • Libtayo® (cemiplimab for injection) Now Reimbursed in Seven . . .
    Our cancer strategy is powered by cutting-edge technologies and therapies that can be flexibly combined to investigate potentially transformative treatments for patients
  • Cemiplimab Uses, Side Effects Warnings - Drugs. com
    Cemiplimab side effects Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat Seek medical treatment if you have a serious drug reaction that can affect many parts of your body Symptoms may include fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes
  • label - accessdata. fda. gov
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Libtayo (cemiplimab) dosing, indications, interactions . . .
    Medscape - Cutaneous squamous cell carcinoma and basal cell carcinoma dosing for Libtayo (cemiplimab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information





中文字典-英文字典  2005-2009